drugset / Trial / NCT06975514
Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to assess efficacy of YZJ-1139 for 28 days in adult subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Timeline
- Start
- 2025-03-25
- Primary completion
- 2025-07-21
- Completion
- 2025-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FAZAMOREXANT | Small molecule | 20 mg | — |
| Comparator | Zolpidem | Small molecule | 10 mg | — |